North America Breast Implants Market

North America Breast Implants Market Size (2023 to 2028)

The North America breast implants market size is expected to grow at a CAGR of 4.63% from 2023 to 2028 and be worth USD 830 million by 2028 from USD 660 million in 2023.

The growing number of breast augmentation cases is one of the primary factors propelling the breast implant market in North America. Breast augmentation is a cosmetic surgery that helps to increase breast size and change shape. For this procedure, healthcare providers use silicone or saline breast implants. Nearly 300,000 breast augmentation surgeries are performed each year in the United States. Breast augmentation is a most personalized surgery in which many women prefer to have what size they need for the placement in the implant surgeries. Most pregnant women lose their breast size after the birth of a child and seem ugly and go through this surgery to regain their breast size and shape. Additionally, people trying to lose weight also have this breast implant surgery because body size decreases after weight loss.

The rising incidence of breast cancer in this region is further accelerating the growth rate of the breast implants market in North America. Nearly 14% of people in the United States are expected to have breast cancer in a lifetime. In recent years, most women have had breast cancer due to changing lifestyles, genetic disorders, decreasing breastfeeding, etc. Many women under breast cancer surgery may have a chance to remove the complete breast to treat or prevent breast cancer. These breasts can be rebuilt using implant surgeries which demand market growth.

Increasing awareness about breast implants and increasing product approvals by the government in this region drives the market forward. Many women get breast implantation to get self-confidence. The government conducts every year of march breast implant awareness programs daily to motivate about taking breast implants as a safe method. These awareness programs explain the details of the breast implant procedure and how it shows after and before the procedure. It also educates about the breast reconstruction option after breast cancer surgeries. Corporate companies support awareness programs that increase breast reconstruction awareness and drive the market demand forward in this region.

However, a lack of awareness among people is showing a significant impact on market growth. Most of the North American region is unaware of breast implant procedures and the benefits to their appearance after the surgery. In addition, post-surgery complications and side effects are anticipated to restrain the market growth. The high cost of the surgery, lack of skilled professionals, and lack of product approvals also hamper the market growth.

This research report on the North American breast implants market has been segmented and sub-segmented into the following categories:

By Product:

• Silicone Breast Implants
• Saline Breast Implants

By Shape:

• Round
• Anatomical

By Application:

• Reconstructive Surgery
• Cosmetic Surgery

By End-Use:

• Hospitals
• Cosmetology Clinics
• Ambulatory Surgical Centers

By Country:

• United States
• Canada
• Rest of North America

The North American breast implant market is anticipated to account for the majority share of the global market over the forecast period. This region's market growth is attributed to factors such as the increasing number of breast implant procedures and increased awareness of cosmetic surgery. According to the American Society of Plastic Surgeons’ 2020 report, breast augmentation was one of the top five cosmetic surgical procedures performed in the United States in 2020, with a total of 193,073 treatments conducted. In addition, the rising prevalence of breast cancer in North America will also help the region’s breast implant industry rise. In the GLOBOCAN 2020 research, however, there was a significant increase in breast cancer causes both in the United States and Canada; North America is predicted to have a considerable market share in the breast implant market throughout the forecasted period.

The United States is expected to lead the North American market during the forecast period. The rising prevalence and incidence of breast cancer in the United States and the increasing usage of multifunctional modifiers in beauty and skincare products propel the market growth. Furthermore, the growing number of women choosing reconstruction treatments would boost the market’s growth in the United States. In addition, Breast implant adoption is predicted to increase as the number of plastic surgeons increases. This increased acceptance of breast implant treatments will boost the market for breast implants in the United States.

The Canadian market is anticipated to showcase a healthy CAGR during the forecast period. Health Canada has followed several safety guidelines for breast implant products' safety to reduce the risk after surgery. Most of the Implants available in Canada are silicone shells. The Canadian government has approved most silicone implants because they feel softer and decrease the chance to cause rippling. Many key players are working on manufacturing different types of implants according to the different types of people they are seeing. They also use quality material to make the shell placed under the breast to increase the size and reshape the breast. In 2022, Sientra received approval from Health Canada to sell its silicone gel breast implants in this region. 

KEY MARKET PLAYERS:

AbbVie Inc. (Allergan plc), Establishment Labs SA, GC Aesthetics, Groupe Sebbin SAS, Laboratories Arion, Johnson & Johnson (Mentor Worldwide LLC), Polytech Health & Aesthetics GmbH, Silimed, Sientra Inc., and Celaplas are some of the noteworthy companies in the North America breast implants market.